Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (171-180 of 400) with videos related to

Pageof 40
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancerMichael Souvatzoglou, Bernd J Krause, Anja Pürschel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancerB J Krause, M Souvatzoglou, M Tuncel, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Peptide Receptor Radionuclide Therapy for SarcoidosisConstantin Lapa, Götz Ulrich Grigoleit, Heribert Hänscheid, et al.
British Journal of Haematology|May 4, 2017
[<sup>11</sup> C]Methionine emerges as a new biomarker for tracking active myeloma lesionsConstantin Lapa, Martin Schreder, Katharina Lückerath, et al.
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapySong Xue, Sabrina Kraus, Johanna S Enke, et al.
Molecular Imaging and Biology|April 3, 2009
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomasKen Herrmann, Toshiki Takei, Kakuko Kanegae, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 16, 2015
ETORPHINE-KETAMINE-MEDETOMIDINE TOTAL INTRAVENOUS ANESTHESIA IN WILD IMPALA (AEPYCEROS MELAMPUS) OF 120-MINUTE DURATIONGareth E Zeiler, George F Stegmann, Geoffrey Fosgate, et al.
Neuroimage|April 22, 2008
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET studyAndrea G Ludolph, Jan Kassubek, Klaus Schmeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2025
<sup>131</sup>I SPECT/CT provides prognostic information in patients with differentiated thyroid cancerMarieke Heinrich, Elias Blickle, Philipp E Hartrampf, et al.
Pageof 40

Showing results (171-180 of 400) with videos related to

Sort By:
Pageof 40
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Influence of (11)C-choline PET/CT on the treatment planning for salvage radiation therapy in patients with biochemical recurrence of prostate cancerMichael Souvatzoglou, Bernd J Krause, Anja Pürschel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 25, 2007
The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancerB J Krause, M Souvatzoglou, M Tuncel, et al.
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Peptide Receptor Radionuclide Therapy for SarcoidosisConstantin Lapa, Götz Ulrich Grigoleit, Heribert Hänscheid, et al.
British Journal of Haematology|May 4, 2017
[<sup>11</sup> C]Methionine emerges as a new biomarker for tracking active myeloma lesionsConstantin Lapa, Martin Schreder, Katharina Lückerath, et al.
Clinical Nuclear Medicine|December 5, 2013
Three-phase bone scintigraphy for imaging osteoradionecrosis of the jawConstantin Lapa, Christian Linz, Christina Bluemel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 18, 2026
Lesion-level dual-tracer PET biomarkers predict prognosis in multiple myeloma treated with CXCR4-directed radiopharmaceutical therapySong Xue, Sabrina Kraus, Johanna S Enke, et al.
Molecular Imaging and Biology|April 3, 2009
Clinical value and limitations of [11C]-methionine PET for detection and localization of suspected parathyroid adenomasKen Herrmann, Toshiki Takei, Kakuko Kanegae, et al.
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 16, 2015
ETORPHINE-KETAMINE-MEDETOMIDINE TOTAL INTRAVENOUS ANESTHESIA IN WILD IMPALA (AEPYCEROS MELAMPUS) OF 120-MINUTE DURATIONGareth E Zeiler, George F Stegmann, Geoffrey Fosgate, et al.
Neuroimage|April 22, 2008
Dopaminergic dysfunction in attention deficit hyperactivity disorder (ADHD), differences between pharmacologically treated and never treated young adults: a 3,4-dihdroxy-6-[18F]fluorophenyl-l-alanine PET studyAndrea G Ludolph, Jan Kassubek, Klaus Schmeck, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 15, 2025
<sup>131</sup>I SPECT/CT provides prognostic information in patients with differentiated thyroid cancerMarieke Heinrich, Elias Blickle, Philipp E Hartrampf, et al.
Pageof 40